What is the appropriate amoxicillin oral suspension dose for an 11-year-old child weighing 44.3 kg with acute otitis media?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Amoxicillin Dosing for Acute Otitis Media

For an 11-year-old child weighing 44.3 kg with acute otitis media, prescribe high-dose amoxicillin at 80-90 mg/kg/day divided into two doses, which equals 1770-1990 mg per day total, given as approximately 885-995 mg twice daily (every 12 hours).

Dosing Calculation and Rationale

Based on the 2013 American Academy of Pediatrics guideline for acute otitis media management, high-dose amoxicillin (80-90 mg/kg/day in 2 divided doses) is the recommended first-line treatment 1. This recommendation is driven by the need to cover increasingly resistant Streptococcus pneumoniae and beta-lactamase producing Haemophilus influenzae.

For your patient:

  • Weight: 44.3 kg
  • Recommended dose: 80-90 mg/kg/day
  • Calculation: 44.3 kg × 80-90 mg/kg = 3,544-3,987 mg/day
  • Divided into 2 doses: approximately 1,772-1,994 mg per dose

Critical Dosing Consideration: The "Adult Maximum" Problem

However, there is an important clinical reality you must address: The FDA labeling indicates that for ear/nose/throat infections of severe intensity in children weighing ≥40 kg, the dosing follows adult recommendations of 875 mg every 12 hours or 500 mg every 8 hours 2. This creates a significant discrepancy, as 875 mg twice daily equals only 1,750 mg/day total (approximately 39.5 mg/kg/day for this patient)—less than half the guideline-recommended dose.

Recent research confirms this problematic pattern: larger children consistently receive declining doses per kilogram, with most patients above 60 kg dosed at less than 40 mg/kg/day, and children reaching "adult maximum doses" at weights as low as 20 kg 3. This represents a critical gap between guideline recommendations and real-world prescribing.

Practical Prescribing Recommendation

Given this child weighs over 40 kg, you have two evidence-based options:

Option 1 (Preferred for Guideline Adherence):

  • Prescribe 1,000 mg (using 400 mg/5 mL suspension) twice daily
  • This provides approximately 2,000 mg/day (45 mg/kg/day)
  • While below the ideal 80-90 mg/kg/day, this exceeds the standard adult dose and represents a reasonable compromise

Option 2 (Conservative Approach):

  • Prescribe 875 mg tablets twice daily (if the child can swallow tablets)
  • This provides 1,750 mg/day (39.5 mg/kg/day)
  • This follows FDA labeling but falls short of guideline recommendations

Important Clinical Caveats

Do NOT prescribe high-dose amoxicillin-clavulanate as first-line unless the child has:

  • Taken amoxicillin in the previous 30 days
  • Concurrent purulent conjunctivitis (otitis-conjunctivitis syndrome)
  • Failed initial amoxicillin therapy after 48-72 hours 1

Treatment duration: Continue for minimum 48-72 hours beyond symptom resolution. For Streptococcus pyogenes (though less common in AOM), treat for at least 10 days to prevent acute rheumatic fever 2.

Suspension preparation: If using oral suspension, shake well before each dose. Refrigeration is preferable but not required. Discard unused portion after 14 days 2.

Monitoring for Treatment Failure

Reassess at 48-72 hours. If symptoms persist or worsen, switch to high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin component with 6.4 mg/kg/day of clavulanate in 2 divided doses) 1.

The evidence supporting amoxicillin remains strong despite increasing beta-lactamase-producing bacteria, with recent data showing treatment failure rates of only 5.4% and no significant difference in outcomes based on beta-lactamase production 4.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.